ZA200901216B - Method for treating cancer harboring EGFR mutations - Google Patents
Method for treating cancer harboring EGFR mutationsInfo
- Publication number
- ZA200901216B ZA200901216B ZA200901216A ZA200901216A ZA200901216B ZA 200901216 B ZA200901216 B ZA 200901216B ZA 200901216 A ZA200901216 A ZA 200901216A ZA 200901216 A ZA200901216 A ZA 200901216A ZA 200901216 B ZA200901216 B ZA 200901216B
- Authority
- ZA
- South Africa
- Prior art keywords
- treating cancer
- egfr mutations
- cancer harboring
- harboring egfr
- mutations
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06120856 | 2006-09-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200901216B true ZA200901216B (en) | 2010-03-31 |
Family
ID=41040415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200901216A ZA200901216B (en) | 2006-09-18 | 2009-02-20 | Method for treating cancer harboring EGFR mutations |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101516376A (en) |
ZA (1) | ZA200901216B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140139510A (en) * | 2012-03-28 | 2014-12-05 | 다나-파버 캔서 인스티튜트 인크. | C-raf mutants that confer resistance to raf inhibitors |
CN103575900B (en) * | 2012-07-23 | 2015-10-21 | 苏州长光华医生物试剂有限公司 | A kind ofly detect kit of ERBB2 albumen and preparation method thereof |
CN105420194B (en) * | 2015-12-21 | 2019-11-19 | 中南大学湘雅医院 | The alpha mediated progesterone of mPR adjusts lung adenocarcinoma cell to the method for EGFR-TKIs sensibility |
AU2017363199B2 (en) * | 2016-11-17 | 2023-08-17 | Board Of Regents, The University Of Texas System | Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations |
CN111527103A (en) * | 2017-09-08 | 2020-08-11 | 科罗拉多大学董事会,法人团体 | Compounds, compositions and methods for treating or preventing HER-driven drug resistant cancers |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102886045A (en) * | 2005-02-03 | 2013-01-23 | 综合医院公司 | Method for treating gefitinib resistant cancer |
-
2007
- 2007-09-14 CN CNA2007800345541A patent/CN101516376A/en active Pending
-
2009
- 2009-02-20 ZA ZA200901216A patent/ZA200901216B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101516376A (en) | 2009-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL197914A (en) | Anti-ereg antibodies for treating cancer | |
IL198851A0 (en) | Methods for treating hypercholesterolemia | |
GB2445867B (en) | Method for reducing acrylamide formation | |
EP1909854A4 (en) | Method for treating cancer | |
ZA200904983B (en) | Method for reducing acrylamide formation | |
EP1991230A4 (en) | Methods of treating cancer | |
HK1131577A1 (en) | Compositions for treating cancer | |
ZA200805760B (en) | Method for treating disseminated cancer | |
ZA201003123B (en) | Thiazol derivavtives for treating cancer | |
IL213398A0 (en) | Compounds for treating cancer | |
IL196208A0 (en) | Methods for cancer treatment using tak1 inhibitors | |
EP2144504A4 (en) | Method of treating brain cancer | |
IL238394A0 (en) | Cancer treatment method | |
IL199689A0 (en) | Compounds and method for treatment of cancer | |
EP2144888A4 (en) | Methods for treating cancer | |
ZA200901216B (en) | Method for treating cancer harboring EGFR mutations | |
EP2029172A4 (en) | Anti-c35 antibodies for treating cancer | |
EP2225226A4 (en) | Compounds and method for treatment of cancer | |
EP2035439A4 (en) | Assessment of risk for colorectal cancer | |
EP2088862A4 (en) | Cancer treatment method | |
EP2068911A4 (en) | Methods for treating cancer | |
EP2281575A4 (en) | Antibodies for treating cancer | |
HK1225304A1 (en) | Treating bone cancer | |
PT2509599E (en) | Method for treating pancreatic cancer | |
GB0707556D0 (en) | Treatment for cancer |